Background: A common complication in patients receiving home parenteral nutrition (HPN) is catheter-related bloodstream infections (CRBSIs). The CRBSI incidence has been advocated as an outcome parameter assessing the quality of care. This study aimed to illustrate how the use of different CRBSI definitions affects the reported incidence. Materials and Methods: In an observational study based on the Copenhagen intestinal failure database, all clinically reported CRBSIs from 2002-2013 were compared with data from the affiliated microbiological database according to recommended CRBSI criteria. Results: Clinically, 1034 CRBSIs were observed in 548 adults receiving HPN for 1410 catheter-years. Thus, the clinically assessed CRBSI incidence was 1.95/1000 catheter-days. However, based on the microbiological evaluation, only 47% of our episodes fulfilled the Centers for Disease Control and Prevention (CDC) and European Society for Clinical Nutrition (ESPEN) CRBSI criteria. Employing a catheter-salvaging strategy, 40% of the CRBSI diagnoses were supported by the paired blood culture positivity criteria and only 6% by a positive catheter tip. In 53%, CRBSIs were categorized as a clinical or "probable CRBSI" diagnosis. In 20% of all episodes, missing information/blood cultures hampered a CDC/ESPEN CRBSI diagnosis. Thereby, according to CDC/ESPEN CRBSI definitions, the incidence was 0.92/1000 days or 46% lower than clinically assessed. Conclusion: This study illustrates the practical and methodological challenges and great variability in reporting of the CRBSI incidence. Nonetheless, it is recommended as a marker of the quality of care. Consensus regarding CRBSI definitions is a prerequisite for a meaningful comparison of this important outcome parameter between HPN centers. (JPEN J Parenter Enteral Nutr. 2018;42:393-402) 
Introduction
Patients with chronic intestinal failure (IF) depend on parenteral macronutrient, fluid, and/or electrolyte support to maintain health. 1 Home parenteral nutrition (HPN) may be lifesaving, but the concurrent need for a central venous catheter (CVC) carries a well-known, constant risk of catheter-related bloodstream infections (CRBSIs), which impairs the quality of life of patients with IF, 2 frequently leads to costly hospital readmissions, [3] [4] [5] [6] and may even cause death. [7] [8] [9] [10] The incidence of CRBSI is often used as a surrogate marker of the overall quality of care in HPN patients. 1, [11] [12] [13] Therefore, when evaluating the CRBSI incidence within or between IF centers or in relation to benchmarking, quality improvement, or research initiatives, attention to using the same diagnostic procedures and tools as well as applying the same CRBSI definitions is important. 6 Among HPN healthcare providers, the clinical CRBSI diagnosis is frequently based on the occurrence of systemic symptoms of infection in a patient with a CVC, where no other apparent source of an infection is found and with microbiological evidence supporting the CVC as the focus of the infection. 1, 3, 14 A definitive CRBSI diagnosis is confirmed by detection of the same microorganism (species and antibiograms) from a culture of the CVC tip and in at least 1, preferably peripheral, blood culture. 1, 3, 15 However, since a catheter-salvaging strategy is frequently attempted in HPN patients to preserve lifelong central vein access, 1 this excludes the definitive CRBSI diagnosis, including the CVC tip, in the majority of CRBSI cases. Consequently, when catheter salvage is attempted, the CRBSI diagnosis may rely on detection of the same microorganism in simultaneous paired blood cultures drawn through the CVC and a peripheral vein. The microbiological diagnostic methods to most accurately detect a CRBSI are ideally based on quantitative or qualitative culture methods. When employing quantitative cultures, the CRBSI diagnosis with the highest sensitivity and specificity is given, when the colony-forming units (CFU) in the cultures from the CVC are at least 3-fold higher than in the peripheral cultures. 3, 16 In qualitative analyses, the CRBSI diagnosis with the highest sensitivity is given, when automated continuous monitoring of detection of microbial growth occurs at least 2 hours before in the CVC cultures than in the peripheral cultures (differential time to positivity, DTP). 3, 16 However, availability and adherence to these strict microbiological principles vary in clinical practices. The quality and completeness of the collection and registration of blood cultures may also vary depending on the attention and resources spent on this in the clinical setting. 6, 17, 18 Only few studies have described the outcome of the reported CRBSI incidence comparing a clinical CRBSI diagnosis to the strict microbiological CRBSI definitions recommended by the Centers for Disease Control and Prevention (CDC) and European Society for Clinical Nutrition and Metabolism (ESPEN). 1, 3, 15 Therefore, the aim of this retrospective observational study was to illustrate how variation in the application and interpretation of these different CRBSI definitions affected the reported outcome in a large cohort of adult patients with IF receiving HPN at Rigshospitalet in Copenhagen, Denmark, in the period from 2002-2013.
Materials and Methods
The present observational study is based on the singlecenter Copenhagen IF database, which is a web-based research tool. 19 The database is founded on a systematic, retrospective review of medical charts from all adult patients with IF planned to be discharged with HPN from Rigshospitalet since 1970. Our tertiary referral IF unit is the largest out of 4 IF centers in Denmark. The database has been approved and fulfills the requirements of the Danish Data Protection Agency (jr.no.2007-58-0015-30-0854) and the Danish Health authorities (jr.no.3-3013-1538/1).
The study was confined to the period from January 1, 2002, to December 31, 2012 , allowing for all CRBSIrelated data to be verified and compared with data from a microbiological database from the Department of Clinical Microbiology at Rigshospitalet. Information from the microbiological database included type of material (eg, blood, CVC tip, urine, sputum); date of culture performance; blood culture location (peripheral/CVC); final microbiological result, both negative and positive; and all microbial species and their antibiograms.
The Diagnostic Tests
At Rigshospitalet, the microbiological CRBSI diagnosis was ideally based on paired and simultaneously drawn peripheral and CVC blood cultures. When possible, 1 aerobic and 1 anaerobic blood culture flask were drawn from both locations. The qualitative and automated blood culture system BACTEC 9240 (Becton Dickinson, Sparks, MD) was used, and microbial identification with the matrix assisted laser desorption ionization-time of flight (MALDI-TOF) technique 20 (Bruker, Billerica, MA) was enrolled in 2009. Before 2009, microbial identification was performed with the API kit (BioMeriuex, Durham, NC) of automatic systems for identification and analyzed on an ATB expression 1550 Vitek System (BioMeriux). Susceptibility to antimicrobials was estimated by disk diffusion on blood agar using Neosensitablets (Rosco, Taastrup, Denmark). For CVC tip diagnostics, the semi-quantitative roll plate method according to Maki et al 21 was used. The DTP results were not available for the entire study period, and when they were introduced, they were not available to the clinicians in the IF unit and therefore not included in our microbiological evaluation of the CRBSI diagnosis.
The CRBSI Definition
According to the Copenhagen IF database definition, an infectious episode in a patient with a tunneled CVC was regarded as a CRBSI if the patient had clinical symptoms of infection (fever, shivering/chills, nonspecific feeling of being unwell, eg, in relation to infusion through the CVC), elevation of biochemical blood tests indicating infection (white blood cell count and/or C-reactive protein [CRP]), and/or a positive blood culture from the CVC and/or from a peripheral vein. Furthermore, the clinicians should have judged the tunneled CVC as the most likely source of the infection and consequently treated the patient with antimicrobial therapy. Thus, this is a modified CRBSI definition in between the definition of a central line-associated bloodstream infection (CLABSI) made by the CDC/National Healthcare Safety Network (NHSN) for surveillance purposes and the strict CDC/ESPEN microbiological CRBSI definition. 6, 17, 18, 22, 23 A CLABSI is defined as a primary bloodstream infection (BSI) (no other recognized infectious focus) in a patient with a central line within the 48 hours before development of the BSI, with detection in blood cultures of a known pathogen or ࣙ2 blood cultures with detection of skin commensal microorganisms. The CVC tip diagnostics is not a criterion in the CLABSI definition.
18,22

Preselection Criteria for Blood Culture Performance in the IF Unit
According to the standard procedures at Rigshospitalet, all patients with IF with a tunneled CVC who were admitted based on a suspicion of infection ideally should have simultaneous paired blood cultures drawn before the initiation of antimicrobial therapy. Based on the clinical presentation of the patient, supplemental material for microbiological culturing (eg, urine, sputum) should be taken, and when relevant, additional diagnostic examinations (eg, chest xray, ultrasonography, and echocardiography) should be performed. A blood cultures episode was regarded as the same episode if blood cultures were taken within 14 days and demonstrated identical microorganisms.
CRBSI Treatment
The treatment guideline of the IF unit advocated for empiric initiation of intravenous antimicrobial therapy with cefuroxime (1500 mg 3 times daily) and ciprofloxacin (400 mg 2 times daily) on the clinical suspicion of a CRBSI with subsequent adjustments of the antimicrobials when species and antibiograms were provided. No antibiotic catheter locks or thrombolytic agents were used in the treatment of CRBSIs. Heparin 100 IE/mL (5 mL) was the standard prophylactic catheter lock. As recommended in international guidelines, a catheter salvage strategy was followed. 1, 24 At admission, infusions via the tunneled CVC were paused, and a peripheral access was used. With regard to the clinical presentation of the patient, infusion through the tunneled CVC was attempted approximately 24 hours after the peripheral loading with antimicrobials. If the use of the CVC was successful without development of symptoms of infection, the antimicrobials and regular parenteral nutrition (PN)/fluid program were infused through the tunneled CVC for the rest of the treatment period (10-14 days). The tunneled CVC was removed in case of severe sepsis or septic shock, sustained clinical symptoms (fever, shivering/chills), symptoms when CVC was used, detection of a fungal infection, tunnel infection, metastatic infection (eg, endocarditis), central venous thrombosis, or concurrent mechanical CVC problems. Because of the initial catheter salvage strategy, almost all patients would have received systemic antimicrobials at the time of catheter removal. Table 1 illustrates a categorization of all CRBSIs, registered in the Copenhagen IF database from 2002-2013, based on microbiological and clinical findings. By criterion A (the CVC tip and blood culture positivity criterion), the CRBSI diagnosis was based on the rigorous CDC and ESPEN definition, 1, 3, 22 which required a positive CVC tip culture. In cases where a catheter salvage strategy was successful, the CRBSI diagnosis was given by criterion B (the paired blood culture positivity criterion), again according to the CDC and ESPEN definition, with the exception that DTP was not employed. To allow for more clinically based diagnoses of CRBSIs, the "probable CRBSI diagnoses" were subdivided and ranked according to criteria C-H based on the presence of indicators suggesting the CVC as the source of the infection. For details of criteria C-H, see Table 1 .
Categorization of CRBSIs According to Microbiological and Clinical Findings
Statistical Analysis
Descriptive statistics are presented as number or percentages with mean ± SD from 2002-2013. When medians and ranges are presented, this is specified. The paired t test was used to determine the statistical significance of the differences between mean CRBSI incidences/1000 CVCdays for CDC/ESPEN and Copenhagen IF database CRBSI definitions. A P value <.05 was considered statistically significant. The statistical software used was Statistical Analysis System (SAS) 9.4 (SAS Institute, Cary, NC). The locations of the drawn blood culture pairs were not registered. If identical microorganism (species and antibiograms) was detected in both pairs, these episodes were registered under criterion B. If the criteria for CVC tip positivity and blood culture positivity were fulfilled, the episode were categorized as criterion A.
Results
From
"Probable CRBSI diagnosis": practical circumstances prevented a more specific categorization as fulfilling either CVC or peripheral positivity criteria. In the observation period, a total of 3188 blood culture episodes were registered in the microbiological database in the 548 HPN patients (Figure 1 ). The evaluation of all blood culture episodes showed a mean blood culture positivity rate of 40% ± 6%, with 30% ± 4% leading to a CRBSI diagnosis, 7% ± 3% assessed as a bacteremia with another source of the bloodstream infection than the tunneled CVC, and 3% ± 2% assessed as a contaminant where no antimicrobial therapy was initiated. In 8 registered CRBSI episodes (0.7%), the documentation of the blood culture results could only be found in the patient records and not in the microbiological database; these 8 episodes were registered as a culture-positive episode because a microorganism was mentioned in the patient records. The rest of the CRBSI episodes had a least 1 blood culture documented.
A total of 1034 CRBSIs were demonstrated in 279 patients (51%), while 269 patients (49%) did not experience any CRBSIs. The annual CRBSI incidence is shown in Table  2 . According to the Copenhagen IF database definition, the overall CRBSI incidence was 1.95 ± 0.57 CRBSI episodes/1000 tunneled CVC-days in the study period (Table 2) .
In 584 of the CRBSI episodes (57% ± 5%), the CVC was left in situ as part of the catheter-salvage strategy (Figure 1 ). For the CVCs left in situ, 41% (240/584) fulfilled criterion B (the paired blood culture positivity criterion). In 450 episodes (43% ± 5%), the CVC was either changed (n = 427) or permanently removed (n = 23) in relation to the infectious episode. Of the 450 removed CVCs, only 305 CVC tips (68%) were received for semi-quantitative CVC tip analysis (Table 3 ). In 60% of the CVC tips (183/305), no microbial growth was detected. In 31% of the positive tips (38/122), the detected microorganism potentially represented contamination inflicted during the CVC removal procedure (common skin commensals not present in the blood cultures). Consequently, in only 13% of all the CRBSI episodes with CVC removal (60/450), the CRBSI diagnosis was given according to the CDC/ESPEN definition, criterion A (CVC tip and blood culture positivity criterion). In 62% of the episodes in criterion A (37/60), criterion B (paired blood culture positivity criterion) was also fulfilled. In 42% of the cases with CVC removal (190/450), the CVC tip diagnostic did not contribute to the definitive CRBSI diagnosis (Figure 1 ), but the cases fulfilled criterion B (paired blood culture positivity). Therefore, the CRBSI diagnosis was made before CVC removal based on the blood culture results.
In total, in 430 of 1034 episodes (40% ± 5%), the same microorganism (species and antibiograms) was detected in the CVC and peripheral vein blood cultures, fulfilling criterion B (paired blood culture positivity criterion) (Figure 1 ) and the CDC/ESPEN criteria.
The rest of the episodes were diagnosed according to our more clinically based CRBSI criteria with the distribution between the criteria illustrated in Table 4 . They fulfilled criterion C (double-flasks central positivity criterion) in 242 of 1034 episodes (21% ± 6%) and criterion D (single-flask central positivity criterion) in 143 of 1034 episodes (13% ± 5%), with an increase over time in the proportion of episodes diagnosed after these 2 more clinical criteria. Episodes categorized according to criterion E (isolated peripheral positivity criterion) accounted for 34 of 1034 (3% ± 2%), but in 47% of these episodes (16/34) , the CVC blood cultures were missing. Criterion F (missing information CRBSI criterion) accounted for 103 of 1034 episodes (14% ± 15%) but tended to decrease over the study period. Furthermore, in 8% (84/1034), no peripheral blood cultures were registered, and in 2% (19/1034) , no CVC blood cultures were registered (Table 4) .
Of the 1034 CRBSI episodes, 65 (6% ± 3%) were diagnosed and treated at other hospitals. These CRBSIs accounted for 3% in 2002 and increased to 11% in 2012 (Table 2) . Four CRBSI-related deaths occurred in the study period. The causative microorganisms are illustrated in Table 5 , and Table 4 presents the diagnostic criteria by which these CRBSI diagnoses were made. In summary, in total, only 490 of 1034 episodes fulfilled criterion A or criterion B, the strict CDC/ESPEN criteria for a definitive CRBSI diagnosis. Accordingly, this CRBSI incidence was 0.92 ± 0.34 episodes/1000 tunneled CVC-days or 46% lower than the more clinically based Copenhagen IF database incidence (Table 2) . Table 5 illustrates the microbial pattern of the CRBSIs in our HPN population. The monoinfections accounted for 65.4% ± 8.4% of the CRBSIs, but a high rate of both polyinfections (23.4% ± 4.7%) and fungal infections (12.0% ± 5.7%) was found. The most common group of microorganisms isolated were the Enterobacteriaceae (40.2% ± 11.4%), with the subgroup of Klebsiella species (23.7% ± 8.9%) being more common than Escherichia coli (12.8% ± 4.4%). The coagulase-negative staphylococci (CoNS) accounted for 34.4% ± 10.5% of the isolates over the study period, increasing from 20% in 2002 to 49% in 2012. Only 73 CRBSI episodes (7.9% ± 3.1%) were related to Staphylococcus aureus, but no methicillin-resistant S aureus (MRSA) infections were encountered. Among the fungal infections, the predominant species were Candida glabrata (55/123; 46.2%) and Candida albicans (29/123; 24.4%). 
Discussion
Combining a meticulous microbiological evaluation with clinical data of high validity obtained in a well-controlled, single-center, adult HPN cohort, this observational study illustrates that the "CDC/ESPEN CRBSI incidence," strictly defined according to the microbiological CRBSI criteria, yields an estimate of only 46% compared with the "clinically assessed incidence." Thus, whereas "the CRBSI incidence," in general terms, has been advocated as a surrogate marker of the quality of care in patients with IF receiving HPN, 1, [11] [12] [13] this study illustrates the challenges and practical feasibility of this opinion, exemplifying the need to adhere to standardized clinical diagnostic procedures, uniform microbiological diagnostic methods and methodologies, and ultimately CRBSI definitions.
In this study, a modified CRBSI definition with a high clinical focus, similar to the CLABSI definition, recommended for surveillance purposes, was used. 6, 17, 18, 22 The strict microbiological CRBSI definition requires availability, resources, and adherence to procedures, which, as this study has demonstrated, can be difficult to fulfill in a clinical setting. In 20% of all registered CRBSIs, practical obstacles or missing information ruled out a definitive CRBSI diagnosis. Some studies may underestimate the CRBSI incidence by excluding cases with missing information from their analysis. [25] [26] [27] [28] The strict microbiological CRBSI criteria presuppose a blood culture positivity of 100%, which is not to be expected, and even in cases with severe infectious septicemia, around 30% are found to be culture negative. 29 Practical factors (eg, filling volume, growth media, transportation, and prior antimicrobial therapy) may influence the rate of positive cultures. 25, 26 Inclusion of the blood culture-negative defervescence criteria has been shown to increase the CRBSI incidence by 27%. 25 Furthermore, CRBSIs related to intraluminal biofilm in tunneled longterm CVCs may be more difficult to diagnose with the currently used microbiological methods. 30 The strict microbiological CRBSI definition has been deemed attractive in research settings, because it is clearly defined with a high specificity, but this implies a high risk of underestimating the "true CRBSI incidence" in a clinical setting with a surveillance purpose. 17, 18, 25 Our clinical approach and the use of a modified CRBSI definition has a lower specificity and will tend to overestimate the "true CRBSI incidence." 17, 18, 22, 28 It could be criticized that episodes categorized in criteria C-H, the "probable CRBSIs," carry a higher uncertainty, representing CVC colonization without a systemic bloodstream infection, or even represent a possibility that the CVC is not the primary focus of the infection. Olthof et al 5 reported a similar blood culture positivity distribution in their CRBSIs, where only 44% of their CRBSIs had paired blood culture positivity, and the remaining CRBSIs had isolated CVC blood culture positivity, isolated peripheral positivity, or unknown origin. The isolated CVC blood culture positivity in criterion C (double-flasks central positivity criterion) (21%) and criterion D (single-flasks central positivity criterion) (13%) is a strong indicator of the CVC being the focus of a systemic infection, when clinical and biochemical signs of infection are present, reducing the risk that mere contaminants or CVC colonization are included. 31 Furthermore, due to a higher pretest probability of a bloodstream infection in our high-risk patient population (clinical and biochemical signs of infection, long-term CVC, PN), an increased predictive value of a positive blood culture result could be expected. [31] [32] [33] [34] An argument against the CLABSI definition is that it is impossible to rule out other possible foci of infection. Hereby, the CLABSI incidence will be an overestimation. 28, 35 In this study, this risk is highest in criterion E (isolated peripheral positivity criterion), which represented a low fraction of the CRBSIs (3%).
The DTP method was not used in this study. Results from this study have illustrated that more cumbersome procedures can be difficult in a clinical setting, even in a referral center. DTP greatly depends on that blood cultures are drawn simultaneously (<30 minutes apart), an equal volume and are equivalently stored and transported to minimize external factors that can influence the diagnostic value of DTP. 16 Inclusion of the DTP method requires more microbiological surveillance and assistance. Improper handling, interpretation, and readout could lead to additional unreliability of the "true CRBSI incidence" in a clinical setting.
As illustrated in this study, the relevance of performing and defining a CRBSI by inclusion of CVC tip diagnostics by the semi-quantitative roll plate method 21 can be questioned in an HPN population, in whom early, empiric systemic antimicrobial therapy is a part of the catheter salvage strategy. 26 The 60% CVC tip negativity could also be related to the presence of an intraluminal biofilm as the predominant pathogenesis of the CRBSIs. 3, [36] [37] [38] In only 6% of all our CRBSIs, the CVC tip result supported a definitive microbiological CRBSI diagnosis, and in 62% of these episodes, the CDC/ESPEN recommended CRBSI diagnosis could be made according to the paired blood culture results.
The "true CRBSI incidence" probably lies in between the strict microbiological CRBSI definition recommended by CDC/ESPEN and the CLABSI definition recommended by CDC/NHSN for surveillance purposes. According to local practice, all CRBSI episodes registered in the Copenhagen IF database required hospital admission and systemic antimicrobial therapy. Although probably overestimating the "true CRBSI incidence," this clinical CRBSI incidence provides an accurate estimate of one of the major HPNrelated complications, whereby the associated healthcare resources may be evaluated. It should be emphasized that different national, regional, and institutional requirements may also dictate whether the CRBSI or CLABSI definitions are used in the reporting of this important clinical outcome in the literature. Hospitals receiving public reimbursement in the United States are required to report the CLABSI incidence to NHSN. 23 The CLABSI definition was initially published by the CDC/NHSN as a surveillance definition for central line infections and used for public reporting to evaluate local and national CLABSI prevention programs. However, it should be noted that a financial incentive structure may also influence the reliability of the reported CLABSI rate. 6, 23, 35 Among healthcare workers with a more clinically based interest in HPN, the less stringently defined CLABSI definition or a modified CRBSI definition, reporting the realworld experiences and consequences, has been advocated for. In this article, the large variance in the incidence of central line infections based on these 2 diverse interpretations is presented and nicely illustrates the challenges in an outcome comparison between centers. Currently, the regional reporting of "the CRBSI incidences" most likely is best used as an internal quality marker to assess developments over time and for local benchmark, quality improvements and research initiatives. Awareness of the barriers and challenges related to the comparison between IF centers concerning "the CRBSI incidence" is, however, the first step preceding common initiatives to better define the procedures, tools, and standards for developing a mutually agreed on and clinically applicable CRBSI definition to be used as a global quality outcome measure in the future.
